• Most Popular
  • Most Shared

Memory Pharma says bipolar disorder drug fails trail

Mon Mar 5, 2007 6:00am EST

Regulatory News

March 5 (Reuters) - Memory Pharmaceuticals Corp. MEMY.O said its experimental drug for treating acute mania in bipolar disorder proved ineffective in a mid-stage trial.

However, the company will go ahead with its trials of the drug for use in Alzheimer's disease, it said in a statement.

(Reporting by Anant Vijay Kala in Bangalore)

((Editing by Anil Kumar; Reuters Messaging: anant.kala.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: MEMORY DRUG/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS2926
Regulatory News


More from Reuters

Afghan suicide blast kills eight U.S. civilians

KABUL (Reuters) - A suicide bomber killed eight American civilians in an attack at a military base in southeastern Afghanistan on Wednesday, one of the highest foreign civilian death tolls in an insurgent strike in the eight-year war.

» More Top News
A computer screen image made using Millimeter Wave technology shows a person during a demonstration at the Transporation Security Administration (TSA) Systems Integration Facility in Washington, December 30, 2009. Credit: REUTERS/Jason Reed

Body scans are Obama's call

The Dutch are doing it. So what's taking the U.S. so long to make airport body scanners mandatory?  Full Article | Video 

U.S.
People walk past a branch of Bank of America in New York's financial district April 28, 2009. REUTERS/Brendan McDermid
Rolfe Winkler:

Move your money

Boycotting "too big to fail" banks is a great idea -- so long as investors remember that banks aren't the only ones responsible for the crisis.  Full Article 

    Commentary